The relation between congenital heart block and maternal connective-tissue disease was studied by antibody screening of serum samples obtained in connection with 45 cases of isolated congenital complete heart block. Serum was available from 41 mothers (17 who had connective-tissue disease and 24 who were healthy) and 21 children. Thirty-four mothers had antibody to a soluble tissue ribonucleoprotein antigen called Ro(SS-A), which was identified by immunodiffusion. Anti-Ro(SS-A) was found in seven of eight serum samples collected from affected children when they were less than three months old but in none of 13 samples obtained when these children were older. It appears that maternal anti-Ro(SS-A) antibody crosses the placenta and is a marker for risk of congenital complete heart block; its absence from maternal serum suggests that a child is unlikely to be affected. Anti-Ro(SS-A) or a related antibody is probably involved in the pathogenesis of congenital complete heart block.
This article has been cited by other articles:
Skog, A., Wahren-Herlenius, M., Sundstrom, B., Bremme, K., Sonesson, S.-E.
(2008). Outcome and Growth of Infants Fetally Exposed to Heart Block-Associated Maternal Anti-Ro52/SSA Autoantibodies. Pediatrics
121: e803-e809
[Abstract][Full Text]
Buyon, J. P, Rupel, A., Clancy, R. M
(2003). Congenital heart block: do fetal factors fuel the fire from inflammation to fibrosis?. Lupus
12: 731-734
Brucato, A, Jonzon, A, Friedman, D, Allan, L D, Vignati, G, Gasparini, M, Stein, J I, Montella, S, Michaelsson, M, Buyon, J
(2003). Proposal for a new definition of congenital complete atrioventricular block. Lupus
12: 427-435
[Abstract]
Minassian, V. A., Jazayeri, A.
(2002). Favorable Outcome in a Pregnancy With Complete Fetal Heart Block and Severe Bradycardia. Obstet Gynecol
100: 1087-1089
[Abstract][Full Text]
Restivo, M., Kozhevnikov, D. O., Boutjdir, M.
(2001). Optical mapping of activation patterns in an animal model of congenital heart block. Am. J. Physiol. Heart Circ. Physiol.
280: H1889-H1895
[Abstract][Full Text]
Brucato, A., Cimaz, R., Catelli, L., Meroni, P., Boutjdir, M., El-Sherif, N., Mazel, J. A., Buyon, J.
(2000). Anti-Ro-Associated Sinus Bradycardia in Newborns Response. Circulation
102
: e88-e89
[Full Text]
Watanabe, T., Tsuchida, T., Kanda, N., Mori, K., Hayashi, Y., Tamaki, K.
(1999). Anti-{alpha}-Fodrin Antibodies in Sjogren Syndrome and Lupus Erythematosus. Arch Dermatol
135: 535-539
[Abstract][Full Text]
Sire, M-K, Julkunen, H, Kaaja, R, Kurki, P, Koskimies, S
(1999). Role of HLA in congenital heart block: susceptibility alleles in mothers. Lupus
8: 52-59
[Abstract]
McLeod, K A, Rankin, A C, Houston, A B
(1998). 1:1 atrioventricular conduction in congenital complete heart block. Heart
80: 525-526
[Abstract][Full Text]
Rosenthal, E
(1998). New insights into the pathogenesis of anti-Ro antibody associated congenital complete heart block. Lupus
7: 135-136
Viana, V S., Garcia, S, Nascimento, J H., Elkon, K B, Brot, N, Campos de Carvalho, A C, Bonfa, E
(1998). Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus
7: 141-147
[Abstract]
Boutjdir, M., Chen, L., Zhang, * Z.-H., Tseng, C.-E, DiDonato, * F., Rashbaum, W., Morris, A., El-Sherif, N., Buyon, J. P.
(1997). Arrhythmogenicity of IgG and Anti–52-kD SSA/Ro Affinity-Purified Antibodies From Mothers of Children With Congenital Heart Block. Circ. Res.
80: 354-362
[Abstract][Full Text]
Provost, T., Watson, R., Simmons-O'Brien, E.
(1997). Anti-Ro(SS-A) antibody positive Sjogren's/lupus erythematosus overlap syndrome. Lupus
6: 105-111
[Abstract]
Lee, L., Weston, W.
(1997). Cutaneous lupus erythematosus during the neonatal and childhood periods. Lupus
6: 132-138
[Abstract]
Hubscher, O., Carrillo, D., Reichlin, M.
(1997). Congenital heart block and subsequent connective tissue disorder in adolescence. Lupus
6: 283-284
[Abstract]
Spronk, P. E, Limburg, P. C, Kallenberg, C. G.
(1995). Review : Serological markers of disease activity in systemic lupus erythematosus. Lupus
4: 86-94
[Abstract]
Buyon, J., Waltuck, J., Kleinman, C., Copel, J.
(1995). In Utero identification and therapy of congenital heart block. Lupus
4: 116-121
[Abstract]
Kawashima, T., Zappi, E. G., Lieu, T.-S., Sontheimer, R. D
(1994). Impact of Ultraviolet Irradiation on Expression of SSA/Ro Autoantigenic Polypeptides in Transformed Human Epidermal Keratinocytes. Lupus
3: 493-500
[Abstract]
Buyon, J. P.
(1993). Review: Congenital Complete Heart Block. Lupus
2: 291-295
Meilof, J.F., Frohn-Mulder, Lm.E., Steward, P.A., Szatmari, A., Hess, J., Veldhoven, C.H.A., Smeenk, R.J.T., Swaak, A.J.G.
(1993). Maternal Autoantibodies and Congenital Heart Block: No Evidence for the Existence of a Unique Heart Block-associated Anti-Ro/SS-A Autoantibody Profile. Lupus
2: 239-246
[Abstract]
Mavridis, A. K., Liu Xue Ming, , Hatzipetrou, P., Lentzaris, G., Papanikolaou, N. G., Tzioufas, A. G., Moutsopoulos, H. M.
(1992). Prevalence of Non-Organ-Specific Autoantibodies in Pregnant and Non-Pregnant Healthy Women. Lupus
1: 141-144
[Abstract]
Oviasu, E., Hicks, J., Cameron, J. S.
(1991). The Outcome of Pregnancy in Women with Lupus Nephritis. Lupus
1: 19-25
[Abstract]
Allan, W. C.
(1989). Intraventricular Hemorrhage. J Child Neurol
4: S12-S22
[Abstract]